GE HealthCare Technologies Inc. (GEHC)

Nasdaq · Chicago, Illinois, USA · Founded 2023 · CEO Peter Arduini

Valuation summary

$107.23 fair value versus $81.89 in the market, a difference of +30.9%. Rated Strong Buy.

Fair value per share$107.23
Current share price$81.89
Upside / downside+30.9%
Bear case$62.34
Bull case$173.38
Discount rate (WACC)8.9%
Terminal growth2.50%
Market capitalisation$37B
EV / Sales2.0x

About GE HealthCare Technologies Inc.

Spun off from General Electric in January 2023, though its roots in medical imaging go back over a century. Peter Arduini has been chief executive since 2022. GE HealthCare is one of the world's largest makers of medical imaging equipment — CT, MRI and molecular imaging scanners — as well as ultrasound, patient monitoring and the contrast agents and radioactive tracers used in scans.

Investment case

  • A large installed base of scanners produces service revenue.
  • New AI-enabled imaging and radiopharmaceuticals support growth.
  • Pharmaceutical diagnostics is a high-margin, growing business.

Key risks

  • China, a large market, has seen weak hospital purchasing.
  • Tariffs raise costs on equipment and components.
  • Hospital capital budgets are cyclical.

Recent developments

Revenue by segment

Imaging45%
Advanced Visualization Solutions23%
Pharmaceutical Diagnostics12%
Patient Care Solutions20%

Five-year forecast

RevenueFree cash flow
Year 1$23.1B$2.4B
Year 2$24.7B$2.7B
Year 3$26.4B$3.0B
Year 4$28.2B$3.3B
Year 5$30.1B$3.7B

What the street says

A steady medtech since the spin-off; China and tariffs are the swing factors.

Comparable companies: BSX · IQV · MDLN · TEVA · DXCM · HCA · CI · SYK

Open the interactive model, price chart and sensitivity grid →